Results 1 to 10 of about 71,233 (300)

Amiodarone-related Pneumonitis

Journal of the Formosan Medical Association, 2007
Amiodarone-related pneumonitis is a potentially limiting factor for amiodarone usage. However, it is believed that amiodarone-related pneumonitis is unlikely to occur during low-dose and short courses of therapy. We report three patients who received low-
Sheng-Nan Chang, Juey-Jen Hwang, Kuan-Lih Hsu, Chia-Ti Tsai, Ling-Ping Lai, Jiunn-Lee Lin, Chuen-Den Tseng, Fu-Tien Chiang   +7 more
doaj   +4 more sources

Amiodarone and anaesthesia [PDF]

Canadian Journal of Anaesthesia, 1990
Sallie J. Teasdale, Eugene Downar
openalex   +4 more sources

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source

Prophylactic effect of Amiodarone and in combination with vitamin C in reducing atrial fibrillation after coronary artery bypass

European Journal of Translational Myology, 2021
Atrial fibrillation (AF) is the most common arrhythmia following cardiac surgery, leading to hemodynamic impairment and increased mortality and morbidity after coronary artery bypass grafting (CABG) and increases hospitalization.
Alireza Kamali, Samira Yavari, Bijan Yazdi, Alireza Rostami   +3 more
doaj   +1 more source

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity

BMC Pulmonary Medicine, 2022
Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use.
Wang Chun Kwok, Ting Fung Ma, Johnny Wai Man Chan, Herbert H. Pang, James Chung Man Ho   +4 more
doaj   +1 more source

Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside

Pharmaceutics, 2022
Background: Adjusting drug therapy under veno-venous extracorporeal membrane oxygenation (VV ECMO) is challenging. Although impaired pharmacokinetics (PK) under VV ECMO have been reported for sedative drugs and antibiotics, data about amiodarone are ...
Mickaël Lescroart, Claire Pressiat, Benjamin Péquignot, N’Guyen Tran, Jean-Louis Hébert, Nassib Alsagheer, Nicolas Gambier, Bijan Ghaleh, Julien Scala-Bertola, Bruno Levy   +9 more
doaj   +1 more source

Effect of Amiodarone and Hypothermia on Arrhythmia Substrates During Resuscitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Amiodarone is administered during resuscitation, but its antiarrhythmic effects during targeted temperature management are unknown. The purpose of this study was to determine the effect of both therapeutic hypothermia and amiodarone on ...
Joseph S. Piktel, Yi Suen, Shalen Kouk, Danielle Maleski, Gary Pawlowski, Kenneth R. Laurita, Lance D. Wilson   +6 more
doaj   +1 more source

Amiodarone and the Thyroid [PDF]

QJM: An International Journal of Medicine, 1987
Amiodarone, an iodinated benzofuran derivative, was introduced in the 1960s as an antianginal agent with coronary vasodilator properties. Later description of its antiaiThythmic activity in animals and reports of its unique electrophysiological effects have led to its widespread application as an anti-arrhythmic agent Singh and Vaughan Williams first ...
Jayne A. Franklyn, M. D. Gammage
openaire   +4 more sources

Efficacy of statins combined with amiodarone in the treatment of atrial fibrillation: A meta-analysis

European Journal of Inflammation, 2022
Objectives: Atrial fibrillation (AF) is a common arrhythmia in clinics with a high mortality rate. Recently, statins combined with amiodarone and amiodarone alone were used in the treatment of AF.
Yingbiao Wu, Xi Zhu, Zhongping Ning
doaj   +1 more source

Lipid emulsion mitigates intravenous amiodarone toxicity in a rat model

Toxicology Communications, 2022
Introduction Our study investigated whether lipid emulsion therapy could act as an antidote for intravenous amiodarone toxicity in a rat model.Methods 20 rats were randomised to receive lipid emulsion (ILE) or saline. Rats were infused with amiodarone at
Rachael Stewart, Verity Newman, Martyn Harvey, Mingtan Tang, Zimei Wu, Grant Cave   +5 more
doaj   +1 more source